Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses

Blood

Volumn 122, Issue 6, 2013, Pages 932-942

  Nizzoli, Giulia ^a   Krietsch, Jana ^b,c   Weick, Anja ^b,c   Steinfelder, Svenja ^b,c   Facciotti, Federica ^a   Gruarin, Paola ^a   Bianco, Annalisa ^a   Steckel, Bodo ^b,c   Moro, Monica ^a   Crosti, Mariacristina ^a   Romagnani, Chiara ^b,c   Stölzel, Katharina ^c   Torretta, Sara ^d   Pignataro, Lorenzo ^d   Scheibenbogen, Carmen ^c   Neddermann, Petra ^a   De Francesco, Raffaele ^a   Abrignani, Sergio ^a   Geginat, Jens ^a  

^a National Institute of Molecular Genetics (INGM)   (Italy)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P70; TOLL LIKE RECEPTOR; CD1 ANTIGEN; CD1C PROTEIN, HUMAN; CYTOKINE; GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BDCA 3+ MYELOID DENDRITIC CELL; CD1C 1+ MYELOID DENDRITIC CELL; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL ISOLATION; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY T LYMPHOCYTE; MONONUCLEAR CELL; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIGEN PRESENTATION; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; DENDRITIC CELL; IMMUNOLOGICAL MEMORY; LYMPHOCYTE ACTIVATION; METABOLISM; PHENOTYPE; SECRETION (PROCESS);

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; CYTOKINES; DENDRITIC CELLS; GLYCOPROTEINS; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTORS;

EID: 84886900071     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-04-495424     Document Type: Article

References (53)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673): 245-252.
2. Liu K, Waskow C, Liu X, Yao K, Hoh J, Nussenzweig M. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat Immunol. 2007;8(6):578-583.
3. Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol. 2012;12(8):557-569.
4. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 1998;393(6684):478-480.
5. Dresch C, Leverrier Y, Marvel J, Shortman K. Development of antigen cross-presentation capacity in dendritic cells. Trends Immunol. 2012; 33(8):381-388.
6. Sallusto F, Lanzavecchia A. The instructive role of dendritic cells on T-cell responses. Arthritis Res. 2002;4(suppl 3):S127-S132.
7. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5(8):919-923.
8. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1(4):305-310.
9. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283(5405): 1183-1186.
10. Hoeffel G, Ripoche AC, Matheoud D, et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity. 2007; 27(3):481-492.
11. Mouriès J, Moron G, Schlecht G, Escriou N, Dadaglio G, Leclerc C. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood. 2008;112(9): 3713-3722.
12. Tel J, Schreibelt G, Sittig SP, et al. Human plasmacytoid dendritic cells efficiently crosspresent exogenous Ags to CD81 T-cells, despite lower Ag uptake than myeloid dendritic cell subsets. Blood. 2013;121(3):459-467.
13. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol. 2001;31(11):3388-3393.
14. Penna G, Sozzani S, Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol. 2001; 167(4):1862-1866.
15. Yoneyama H, Matsuno K, Zhang Y, et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol. 2004;16(7): 915-928.
16. Ito T, Yang M, Wang YH, et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med. 2007;204(1):105-115.
17. den Haan JM, Lehar SM, Bevan MJ. CD8(1) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med. 2000;192(12): 1685-1696.
18. Dudziak D, Kamphorst AO, Heidkamp GF, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315(5808): 107-111.
19. Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O'Keeffe M. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol. 2001;166(9): 5448-5455.
20. Reis e Sousa C, Hieny S, Scharton-Kersten T, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med. 1997; 186(11):1819-1829.
21. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165(11):6037-6046.
22. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood. 2002;100(13): 4512-4520.
23. Poulin LF, Salio M, Griessinger E, et al. Characterization of human DNGR-11 BDCA31 leukocytes as putative equivalents of mouse CD8alpha1 dendritic cells. J Exp Med. 2010; 207(6):1261-1271.
24. Bachem A, Güttler S, Hartung E, et al. Superior antigen cross-presentation and XCR1 expression define human CD11c1CD1411 cells as homologues of mouse CD81 dendritic cells. J Exp Med. 2010;207(6):1273-1281.
25. Crozat K, Guiton R, Contreras V, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha1 dendritic cells. J Exp Med. 2010; 207(6):1283-1292.
26. Jongbloed SL, Kassianos AJ, McDonald KJ, et al. Human CD1411 (BDCA-3)1 dendritic cells (DCs) represent a unique myeloid DC subset that crosspresents necrotic cell antigens. J Exp Med. 2010; 207(6):1247-1260.
27. Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med. 2012;209(4):653-660.
28. Poulin LF, Reyal Y, Uronen-Hansson H, et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood. 2012;119(25):6052-6062.
29. Lauterbach H, Bathke B, Gilles S, et al. Mouse CD8alpha1 DCs and human BDCA31 DCs are major producers of IFN-lambda in response to poly IC. J Exp Med. 2010;207(12):2703-2717.
30. Villadangos JA, Shortman K. Found in translation: the human equivalent of mouse CD81 dendritic cells. J Exp Med. 2010;207(6):1131-1134.
31. Mittag D, Proietto AI, Loudovaris T, et al. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J Immunol. 2011;186(11): 6207-6217.
32. Haniffa M, Shin A, Bigley V, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD1031 nonlymphoid dendritic cells. Immunity. 2012; 37(1):60-73.
33. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005;6(8):769-776.
34. Piccioli D, Tavarini S, Borgogni E, et al. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood. 2007; 109(12):5371-5379.
35. Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, Geginat J. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD41 central memory T cells. J Exp Med. 2004;200(6): 725-735.
36. Kamath AT, Pooley J, O'Keeffe MA, et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol. 2000;165(12):6762-6770.
37. Furuta K, Ishido S, Roche PA. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells. Proc Natl Acad Sci USA. 2012;109(47):19380-19385.
38. Macagno A, Napolitani G, Lanzavecchia A, Sallusto F. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 2007;28(5):227-233.
39. den Haan JM, Bevan MJ. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(1) and CD8(-) dendritic cells in vivo. J Exp Med. 2002;196(6): 817-827.
40. Gondois-Rey F, Dental C, Halfon P, Baumert TF, Olive D, Hirsch I. Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1. PLoS ONE. 2009;4(2):e4319.
41. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatmentinduced viral clearance. Nature. 2009;461(7262): 399-401.
42. Hochrein H, O'Keeffe M, Luft T, et al. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med. 2000;192(6):823-833.
43. Shortman K, Heath WR. The CD81 dendritic cell subset. Immunol Rev. 2010;234(1):18-31.
44. Ruedl C, Bachmann MF. CTL priming by CD8(1) and CD8(-) dendritic cells in vivo. Eur J Immunol. 1999;29(11):3762-3767.
45. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD41 T-helper and a T-killer cell. Nature. 1998; 393(6684):474-478.
46. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998;393(6684):480-483.
47. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD41 T cells are required for secondary expansion and memory in CD81 T lymphocytes. Nature. 2003; 421(6925):852-856.
48. Melief CJ. Cancer immunotherapy by dendritic cells. Immunity. 2008;29(3):372-383.
49. Diehl L, den Boer AT, Schoenberger SP, et al. CD40 activation in vivo overcomes peptideinduced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med. 1999;5(7):774-779.
50. Heath WR, Carbone FR. Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol. 2001;1(2):126-134.
51. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685-711.
52. Cohn L, Chatterjee B, Esselborn F, et al. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA31 dendritic cells at cross presentation. J Exp Med. 2013; 210(5):1049-1063.
53. Segura E, Durand M, Amigorena S. Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J Exp Med. 2013;210(5):1035-1047.